SORAFENIB Side Effects

6980287-1 |
on Sep 10, 2010 Female patient from UNITED STATES , 59 years of age, weighting 108.0 lb, was diagnosed with hepatic neoplasm malignant and was treated with Sorafenib (View Usage). . Sorafenib dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. During the same period patient was treated with IMC A12 (CIXUTUMUMAB) (Unit Dose: 20 Mg/kg) (View Imc-a12 (cixutumumab) Review and Imc-a12 (cixutumumab) Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), IMODIUM (View Imodium Review and Imodium Label ), NEOSPORIN (View Neosporin Review and Neosporin Label ), K DUR (View K-dur Review and K-dur Label ).

6980275-5 | Basal Cell Carcinoma, Muscle Strain
Patient was taking Sorafenib (View Usage). Patient had the following side effects: basal cell carcinoma, muscle strain on Sep 09, 2010 from FRANCE Additional patient health information: Male patient , 78 years of age, was diagnosed with renal cell carcinoma, vertigo, hypertension, glaucoma (What is glaucoma?) and. Sorafenib dosage: . During the same period patient was treated with SERC (Total Daily Dose: 24 Mg) (View Serc Review and Serc Label ), LOXEN (Total Daily Dose: 100 Mg) (View Loxen Review and Loxen Label ), XALATAN (Total Daily Dose: 1 Gtt) (View Xalatan Review and Xalatan Label ). Patient was hospitalized.

6978405-4 | Angiodysplasia, Hepatic Encephalopathy
Adverse event was reported on Aug 31, 2010 by a Male patient taking Sorafenib (View Usage) (Dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg) was diagnosed with hepatic neoplasm malignant and. Location: GERMANY , 62 years of age, weighting 205.0 lb, After Sorafenib was administered, patient had the following side effects: angiodysplasia, hepatic encephalopathy. Patient was hospitalized.

6978404-2 | Malignant Ascites
on Aug 31, 2010 Male patient from AUSTRALIA , 70 years of age, was diagnosed with hepatic neoplasm malignant, ascites, medical diet and was treated with Sorafenib (View Usage). Patient experienced the following unwanted or unexpected effects: malignant ascites. Sorafenib dosage: . During the same period patient was treated with FRUSEMIDE (View Frusemide Review and Frusemide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), NADOLOL (View Nadolol Review and Nadolol Label ), FORTISIP (2 Cans) (View Fortisip Review and Fortisip Label ), ALBUMEX 20 (2 Units) (View Albumex 20 Review and Albumex 20 Label ). Patient was hospitalized.


6978342-5 | Cerebral Haemorrhage, Metastases To Central Nervous System
on Sep 03, 2010 Female patient from NETHERLANDS , 57 years of age, was diagnosed with non-small cell lung cancer metastatic and was treated with Sorafenib (View Usage). Patient had the following side effects: cerebral haemorrhage, metastases to central nervous system. Sorafenib dosage: . During the same period patient was treated with METOPROLOL TARTRATE (Total Daily Dose: 100 Mg) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), ASCAL (View Ascal Review and Ascal Label ), TEMAZEPAM (View Temazepam Review and Temazepam Label ), ZOPLICON (View Zoplicon Review and Zoplicon Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ). Patient was hospitalized.

6978270-5 | C-reactive Protein Increased, Hypertension, Palmar-plantar Erythrodysaesthesia Syndrome, Urosepsis
Patient was taking Sorafenib (View Usage). After Sorafenib was administered, patient had the following side effects: c-reactive protein increased, hypertension, palmar-plantar erythrodysaesthesia syndrome, urosepsis on Sep 02, 2010 from CZECH REPUBLIC Additional patient health information: Female patient , 67 years of age, was diagnosed with renal cancer and. Sorafenib dosage: . Patient was hospitalized.

6978269-9 | Blister, Pain In Extremity, Skin Toxicity, Skin Ulcer
Adverse event was reported on Sep 01, 2010 by a Female patient taking Sorafenib (View Usage) (Dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg) was diagnosed with hepatic neoplasm malignant, hypertension and. Location: HONG KONG , 53 years of age, weighting 90.39 lb, Patient experienced the following unwanted or unexpected effects: blister, pain in extremity, skin toxicity, skin ulcer. During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ).

6978268-7 | Basal Cell Carcinoma, Malignant Melanoma
on Sep 01, 2010 Female patient from GERMANY , 71 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib (View Usage). Patient had the following side effects: basal cell carcinoma, malignant melanoma. Sorafenib dosage: Total Daily Dose: 800 Mg. During the same period patient was treated with PEGYLATED INTERFERON ALFA 2B (View Pegylated Interferon Alfa-2b Review and Pegylated Interferon Alfa-2b Label ).

6978267-5 | Basal Cell Carcinoma, Renal Cell Carcinoma, Squamous Cell Carcinoma Of Skin
on Sep 01, 2010 Male patient from GERMANY , 77 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib (View Usage). After Sorafenib was administered, patient had the following side effects: basal cell carcinoma, renal cell carcinoma, squamous cell carcinoma of skin. Sorafenib dosage: Total Daily Dose: 800 Mg.

6978226-2 | Ascites, Hepatorenal Syndrome
Patient was taking Sorafenib (View Usage). Patient experienced the following unwanted or unexpected effects: ascites, hepatorenal syndrome on Sep 02, 2010 from ITALY Additional patient health information: Male patient , 83 years of age, weighting 189.6 lb, was diagnosed with hepatic neoplasm malignant, ascites, infection (What is infection?), encephalopathy and. Sorafenib dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. During the same period patient was treated with DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), CEPHALOSPORIN (View Cephalosporin Review and Cephalosporin Label ), LACTULOSE (2 Spoons) (View Lactulose Review and Lactulose Label ). Patient was hospitalized.

6978204-3 | Ascites, Hepatic Encephalopathy
Adverse event was reported on Aug 25, 2010 by a Male patient taking Sorafenib (View Usage) (Dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg) was diagnosed with hepatic neoplasm malignant, pain (What is pain?), oedema, constipation (What is constipation?) and. Location: SPAIN , 43 years of age, Patient had the following side effects: ascites, hepatic encephalopathy. During the same period patient was treated with ERLOTINIB HYDROCHLORIDE (Total Daily Dose: 150 Mg) (View Erlotinib Hydrochloride Review and Erlotinib Hydrochloride Label ), METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ), FUROSEMIDA (View Furosemida Review and Furosemida Label ), FORTECORTIN (View Fortecortin Review and Fortecortin Label ), SINOGAN (View Sinogan Review and Sinogan Label ), MAGNESIUM CREAM (View Magnesium Cream Review and Magnesium Cream Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), INNOHEP (View Innohep Review and Innohep Label ). Patient was hospitalized.

6976278-7 | Fall, Pyothorax, Subarachnoid Haemorrhage, Thrombocytopenia
on Sep 04, 2010 Female patient from UNITED STATES , 54 years of age, weighting 143.3 lb, was diagnosed with pancreatic carcinoma and was treated with Sorafenib (View Usage). After Sorafenib was administered, patient had the following side effects: fall (What is fall?), pyothorax, subarachnoid haemorrhage, thrombocytopenia. Sorafenib dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. During the same period patient was treated with RDEA119 (Total Daily Dose: 60 Mg) (View Rdea119 Review and Rdea119 Label ). Patient was hospitalized.

6976277-5 | Malignant Ascites
on Aug 31, 2010 Male patient from AUSTRALIA , 70 years of age, was diagnosed with hepatic neoplasm malignant, ascites, medical diet and was treated with Sorafenib (View Usage). Patient experienced the following unwanted or unexpected effects: malignant ascites. Sorafenib dosage: . During the same period patient was treated with FRUSEMIDE (View Frusemide Review and Frusemide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), NADOLOL (View Nadolol Review and Nadolol Label ), FORTISIP (2 Cans) (View Fortisip Review and Fortisip Label ), ALBUMEX 20 (2 Units) (View Albumex 20 Review and Albumex 20 Label ). Patient was hospitalized.

6973599-9 | Cardio-respiratory Arrest
Patient was taking Sorafenib (View Usage). Patient had the following side effects: cardio-respiratory arrest on Sep 07, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 253.5 lb, was diagnosed with renal cell carcinoma and. Sorafenib dosage: .

6972521-9 | Disorientation, Encephalopathy
Adverse event was reported on Sep 03, 2010 by a Male patient taking Sorafenib (View Usage) (Dosage: ) was diagnosed with hepatic neoplasm malignant, hypertension and. Location: RUSSIAN FEDERATION , 81 years of age, weighting 147.7 lb, After Sorafenib was administered, patient had the following side effects: disorientation, encephalopathy. During the same period patient was treated with NIFEDIPINE (View Nifedipine Review and Nifedipine Label ). Patient was hospitalized and became disabled.

6972479-2 | Anaemia, Diarrhoea, Dyspnoea, Fatigue, Hypokalaemia
on Aug 30, 2010 Female patient from UNITED STATES , 65 years of age, weighting 136.7 lb, was diagnosed with colorectal cancer metastatic, unevaluable event, diarrhoea, mineral supplementation and was treated with Sorafenib (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, diarrhoea, dyspnoea, fatigue, hypokalaemia. Sorafenib dosage: Total Daily Dose: 400 Mg Unit Dose: 200 Mg. During the same period patient was treated with RDEA119 (Total Daily Dose: 100 Mg) (View Rdea119 Review and Rdea119 Label ), ALBUTEROL (2 Puffs/inhaler) (View Albuterol Review and Albuterol Label ), MUCINEX (200 Mg) (View Mucinex Review and Mucinex Label ), PROTONIX (View Protonix Review and Protonix Label ), LOMOTIL (2.5 Mg) (View Lomotil Review and Lomotil Label ), FERROUS GEL (Total Daily Dose: 325 Mg) (View Ferrous Gel Review and Ferrous Gel Label ). Patient was hospitalized.

6972478-0 | Febrile Neutropenia, Myositis
on Sep 01, 2010 Male patient from UNITED STATES , 65 years of age, weighting 154.3 lb, was diagnosed with myelodysplastic syndrome and was treated with Sorafenib (View Usage). Patient had the following side effects: febrile neutropenia, myositis (What is myositis?). Sorafenib dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. During the same period patient was treated with PRILOSEC OTC (Total Daily Dose: 1 Df) (View Prilosec Otc Review and Prilosec Otc Label ), ALLEGRA D 24 HOUR (Total Daily Dose: 1 Df) (View Allegra D 24 Hour Review and Allegra D 24 Hour Label ). Patient was hospitalized.

6971245-1 | Convulsion, Deep Vein Thrombosis, Hepatic Neoplasm Malignant, Malignant Neoplasm Progression
Patient was taking Sorafenib (View Usage). After Sorafenib was administered, patient had the following side effects: convulsion, deep vein thrombosis (What is deep vein thrombosis?), hepatic neoplasm malignant, malignant neoplasm progression on Sep 02, 2010 from BRAZIL Additional patient health information: Male patient , 27 years of age, weighting 108.0 lb, was diagnosed with hepatic neoplasm malignant and. Sorafenib dosage: . Patient was hospitalized.

6970343-6 | Confusional State, Decreased Appetite, Fatigue, Hepatic Failure, Hyperbilirubinaemia, Lethargy, Nausea
Adverse event was reported on Aug 27, 2010 by a Male patient taking Sorafenib (View Usage) (Dosage: ) was diagnosed with hepatic neoplasm malignant and. Location: AUSTRALIA , 56 years of age, Patient experienced the following unwanted or unexpected effects: confusional state, decreased appetite, fatigue, hepatic failure, hyperbilirubinaemia, lethargy, nausea (What is nausea?). During the same period patient was treated with AMGEN 386 (View Amgen 386 Review and Amgen 386 Label ), ALBUTEROL SULFATE AUTOHALER (View Albuterol Sulfate Autohaler Review and Albuterol Sulfate Autohaler Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), OXYCODONE HYDROCHOLORIDE (View Oxycodone Hydrocholoride Review and Oxycodone Hydrocholoride Label ), THIAMINE HCL (View Thiamine Hcl Review and Thiamine Hcl Label ), CENTRUM (View Centrum Review and Centrum Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ). Patient was hospitalized.

6970216-9 | Hepatic Encephalopathy, Hepatic Failure, Jaundice, Renal Failure
on Sep 02, 2010 Male patient from UNITED KINGDOM , 63 years of age, weighting 154.3 lb, was diagnosed with renal cell carcinoma, hypertension, dyspepsia and was treated with Sorafenib (View Usage). Patient had the following side effects: hepatic encephalopathy, hepatic failure, jaundice (What is jaundice?), renal failure. Sorafenib dosage: Total Daily Dose: 800 Mg. During the same period patient was treated with BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), ACETAMINOPHEN (Unit Dose: 500 Mg) (View Acetaminophen Review and Acetaminophen Label ), CEFTRIAXONE (Unit Dose: 2 G) (View Ceftriaxone Review and Ceftriaxone Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ACETYLCYSTEINE (Over 15 Mins) (View Acetylcysteine Review and Acetylcysteine Label ). Patient was hospitalized.

6969920-8 | Ascites, Hepatorenal Syndrome
on Sep 02, 2010 Male patient from ITALY , 83 years of age, weighting 189.6 lb, was diagnosed with hepatic neoplasm malignant, ascites, infection (What is infection?), encephalopathy and was treated with Sorafenib (View Usage). After Sorafenib was administered, patient had the following side effects: ascites, hepatorenal syndrome. Sorafenib dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. During the same period patient was treated with DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), CEPHALOSPORIN (View Cephalosporin Review and Cephalosporin Label ), LACTULOSE (2 Spoons) (View Lactulose Review and Lactulose Label ). Patient was hospitalized.

6969909-9 | Dehydration
Patient was taking Sorafenib (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration on Aug 25, 2010 from UNITED STATES Additional patient health information: Male patient , 67 years of age, was diagnosed with hepatic neoplasm malignant, hypertension, ischaemia and. Sorafenib dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. During the same period patient was treated with CAPTOPRIL (Total Daily Dose: 25 Mg) (View Captopril Review and Captopril Label ), BISOPROLOL FUMARATE (Total Daily Dose: 5 Mg) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), URSODIOL (Total Daily Dose: 600 Mg) (View Ursodiol Review and Ursodiol Label ), ORNITHINE (Total Daily Dose: 3 Mg) (View Ornithine Review and Ornithine Label ), SILYBUM MARIANUM (Total Daily Dose: 280 Mg) (View Silybum Marianum Review and Silybum Marianum Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

6969905-1 | Cerebral Haemorrhage, Metastases To Central Nervous System
Adverse event was reported on Aug 24, 2010 by a Female patient taking Sorafenib (View Usage) (Dosage: ) was diagnosed with non-small cell lung cancer metastatic and. Location: NETHERLANDS , 57 years of age, Patient had the following side effects: cerebral haemorrhage, metastases to central nervous system. During the same period patient was treated with METOPROLOL TARTRATE (Total Daily Dose: 100 Mg) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), ASCAL (View Ascal Review and Ascal Label ), TEMAZEPAM (View Temazepam Review and Temazepam Label ), ZOPLICON (View Zoplicon Review and Zoplicon Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ). Patient was hospitalized.

6968854-2 | Fall, Pyothorax, Subarachnoid Haemorrhage, Thrombocytopenia
on Aug 30, 2010 Female patient from UNITED STATES , 54 years of age, weighting 143.3 lb, was diagnosed with pancreatic carcinoma and was treated with Sorafenib (View Usage). After Sorafenib was administered, patient had the following side effects: fall (What is fall?), pyothorax, subarachnoid haemorrhage, thrombocytopenia. Sorafenib dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. During the same period patient was treated with RDEA119 (Total Daily Dose: 100 Mg) (View Rdea119 Review and Rdea119 Label ). Patient was hospitalized.

6968189-8 | Pleural Effusion
on Aug 23, 2010 Female patient from GERMANY , 64 years of age, was diagnosed with renal cell carcinoma and was treated with Sorafenib (View Usage). Patient experienced the following unwanted or unexpected effects: pleural effusion. Sorafenib dosage: Total Daily Dose: 800 Mg. During the same period patient was treated with SUNITINIB MALATE (View Sunitinib Malate Review and Sunitinib Malate Label ), REDUCTO SPEZIAL (View Reducto Spezial Review and Reducto Spezial Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), MOBLOC (View Mobloc Review and Mobloc Label ), CIPRALEX (View Cipralex Review and Cipralex Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ). Patient was hospitalized.

6967906-0 | Aortic Bypass, Peripheral Ischaemia, Toe Amputation
Patient was taking Sorafenib (View Usage). Patient had the following side effects: aortic bypass, peripheral ischaemia, toe amputation on Jul 16, 2010 from FRANCE Additional patient health information: Male patient , 57 years of age, was diagnosed with hepatic neoplasm malignant, varices oesophageal, gastrooesophageal reflux disease, insomnia, arterial occlusive disease, hypertension and. Sorafenib dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. During the same period patient was treated with AVLOCARDYL (View Avlocardyl Review and Avlocardyl Label ), NEXIUM (View Nexium Review and Nexium Label ), STILNOX (View Stilnox Review and Stilnox Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), BIPRETERAX (View Bipreterax Review and Bipreterax Label ). Patient was hospitalized.

6966970-2 | Convulsion, Deep Vein Thrombosis
Adverse event was reported on Aug 26, 2010 by a Male patient taking Sorafenib (View Usage) (Dosage: ) was diagnosed with hepatic neoplasm malignant and. Location: BRAZIL , 27 years of age, weighting 108.0 lb, After Sorafenib was administered, patient had the following side effects: convulsion, deep vein thrombosis (What is deep vein thrombosis?). Patient was hospitalized.

6966969-6 | Hepatic Failure
on Aug 30, 2010 Female patient from UNITED STATES , 57 years of age, weighting 165.3 lb, was diagnosed with hepatic neoplasm malignant, hypertension, ex-tobacco user, cancer pain and was treated with Sorafenib (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic failure. Sorafenib dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. During the same period patient was treated with TRIAMTERENE AND HYDROCHLOROTHIAZIDE (As Used: 37.5/25 Mg) (View Triamterene And Hydrochlorothiazide Review and Triamterene And Hydrochlorothiazide Label ), BUPROPION HCL (Total Daily Dose: 300 Mg) (View Bupropion Hcl Review and Bupropion Hcl Label ), TOPROL XL (Total Daily Dose: 50 Mg) (View Toprol-xl Review and Toprol-xl Label ), OXYCODONE (Total Daily Dose: 30 Mg) (View Oxycodone Review and Oxycodone Label ). Patient was hospitalized.

6966968-4 | Ascites, Hepatic Encephalopathy
on Aug 20, 2010 Male patient from SPAIN , 43 years of age, was diagnosed with hepatic neoplasm malignant, pain (What is pain?), oedema, constipation (What is constipation?) and was treated with Sorafenib (View Usage). Patient had the following side effects: ascites, hepatic encephalopathy. Sorafenib dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. During the same period patient was treated with ERLOTINIB HYDROCHLORIDE (Total Daily Dose: 150 Mg) (View Erlotinib Hydrochloride Review and Erlotinib Hydrochloride Label ), METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ), FUROSEMIDA (View Furosemida Review and Furosemida Label ), FORTECORTIN (View Fortecortin Review and Fortecortin Label ), SINOGAN (7 Drops) (View Sinogan Review and Sinogan Label ), MAGNESIUM CREAM (View Magnesium Cream Review and Magnesium Cream Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), INNOHEP (View Innohep Review and Innohep Label ). Patient was hospitalized.

6965658-1 | Abdominal Pain Upper, Peritonitis
Patient was taking Sorafenib (View Usage). After Sorafenib was administered, patient had the following side effects: abdominal pain upper, peritonitis on Aug 31, 2010 from GERMANY Additional patient health information: Male patient , 72 years of age, was diagnosed with renal cell carcinoma and. Sorafenib dosage: . During the same period patient was treated with AGRENOX (View Agrenox Review and Agrenox Label ), NEXIUM (View Nexium Review and Nexium Label ), CALCIMOGANFATE (View Calcimoganfate Review and Calcimoganfate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

6965121-8 | Hyponatraemia, Skin Ulcer
Adverse event was reported on Aug 19, 2010 by a Male patient taking Sorafenib (View Usage) (Dosage: Total Daily Dose: 400 Mg) was diagnosed with hepatic neoplasm malignant and. Location: TAIWAN, PROVINCE OF CHINA , 56 years of age, weighting 176.4 lb, Patient experienced the following unwanted or unexpected effects: hyponatraemia, skin ulcer. During the same period patient was treated with MOSAPRIDE CITRATE (Total Daily Dose: 15 Mg) (View Mosapride Citrate Review and Mosapride Citrate Label ), MELOXICAM (View Meloxicam Review and Meloxicam Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), SILYMARIN (Total Daily Dose: 450 Mg) (View Silymarin Review and Silymarin Label ), MEGESTROL (Total Daily Dose: 80 Mg) (View Megestrol Review and Megestrol Label ), DILTIAZEM (Long Acting) (View Diltiazem Review and Diltiazem Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6965090-0 | Fall, Pyothorax, Subarachnoid Haemorrhage, Thrombocytopenia
on Aug 30, 2010 Female patient from UNITED STATES , 54 years of age, weighting 143.3 lb, was diagnosed with pancreatic carcinoma and was treated with Sorafenib (View Usage). Patient had the following side effects: fall (What is fall?), pyothorax, subarachnoid haemorrhage, thrombocytopenia. Sorafenib dosage: Total Daily Dose: 400 Mg Unit Dose: 200 Mg. During the same period patient was treated with RDEA119 (Total Daily Dose: 100 Mg) (View Rdea119 Review and Rdea119 Label ). Patient was hospitalized.

6962367-X | Skin Ulcer
on Jul 11, 2010 Male patient from TAIWAN, PROVINCE OF CHINA , 56 years of age, weighting 218.3 lb, was diagnosed with hepatic neoplasm malignant and was treated with Sorafenib (View Usage). After Sorafenib was administered, patient had the following side effects: skin ulcer. Sorafenib dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. Patient was hospitalized.

6961225-4 | Confusional State
Patient was taking Sorafenib (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state on Aug 20, 2010 from BELGIUM Additional patient health information: Male patient , 76 years of age, weighting 185.2 lb, was diagnosed with hepatic neoplasm malignant, decreased appetite, abdominal pain (What is abdominal pain?), hypertension, coronary angioplasty and. Sorafenib dosage: Total Daily Dose: 800 Mg. During the same period patient was treated with PROVERA (View Provera Review and Provera Label ), MOTILIUM (View Motilium Review and Motilium Label ), GAVISCON (250mg/5ml) (View Gaviscon Review and Gaviscon Label ), ZESTORETIC (As Used: 20/12.5 Mg) (View Zestoretic Review and Zestoretic Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

6961218-7 | Ascites
Adverse event was reported on Aug 19, 2010 by a Male patient taking Sorafenib (View Usage) (Dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg) was diagnosed with hepatic neoplasm malignant, abdominal discomfort, blood albumin decreased, hepatitis (What is hepatitis?), hepatic vein thrombosis, ascites and. Location: SINGAPORE , weighting 127.9 lb, Patient had the following side effects: ascites. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), 20% ALBUMIN (View 20% Albumin Review and 20% Albumin Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), CLEXANE (View Clexane Review and Clexane Label ), FRUSEMIDE (View Frusemide Review and Frusemide Label ). Patient was hospitalized.

6960981-9 | Chest Discomfort, Dyspnoea, Electrolyte Imbalance, Nausea, Restlessness
on Aug 20, 2010 Female patient from CHINA , 32 years of age, weighting 121.3 lb, was diagnosed with nasopharyngeal cancer and was treated with Sorafenib (View Usage). After Sorafenib was administered, patient had the following side effects: chest discomfort, dyspnoea, electrolyte imbalance, nausea (What is nausea?), restlessness. Sorafenib dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

6960224-6 | Splenic Infarction
on Aug 26, 2010 Male patient from UNITED STATES , 42 years of age, weighting 121.3 lb, was diagnosed with hepatic neoplasm malignant, hypovitaminosis, hepatitis b (What is hepatitis b?), abdominal pain (What is abdominal pain?), prophylaxis, ascites and was treated with Sorafenib (View Usage). Patient experienced the following unwanted or unexpected effects: splenic infarction. Sorafenib dosage: Total Daily Dose: 400 Mg. During the same period patient was treated with VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ), ENTECAVIR (View Entecavir Review and Entecavir Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), OXYCODONE (Total Daily Dose: 20 Mg) (View Oxycodone Review and Oxycodone Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ). Patient was hospitalized.

6960223-4 | Fall, Pyothorax, Subarachnoid Haemorrhage
Patient was taking Sorafenib (View Usage). Patient had the following side effects: fall (What is fall?), pyothorax, subarachnoid haemorrhage on Aug 25, 2010 from UNITED STATES Additional patient health information: Female patient , 54 years of age, weighting 143.3 lb, was diagnosed with pancreatic carcinoma, depression (What is depression?) and. Sorafenib dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. During the same period patient was treated with RDEA119 (Total Daily Dose: 100 Mg) (View Rdea119 Review and Rdea119 Label ), LEXAPRO (View Lexapro Review and Lexapro Label ). Patient was hospitalized.

6960162-9 | Aortic Bypass, Peripheral Ischaemia, Toe Amputation
Adverse event was reported on Jul 16, 2010 by a Male patient taking Sorafenib (View Usage) (Dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg) was diagnosed with hepatic neoplasm malignant, varices oesophageal, gastrooesophageal reflux disease, insomnia, arterial occlusive disease, hypertension and. Location: FRANCE , 57 years of age, After Sorafenib was administered, patient had the following side effects: aortic bypass, peripheral ischaemia, toe amputation. During the same period patient was treated with AVLOCARDYL (View Avlocardyl Review and Avlocardyl Label ), NEXIUM (View Nexium Review and Nexium Label ), STILNOX (View Stilnox Review and Stilnox Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), BIPRETERAX (View Bipreterax Review and Bipreterax Label ). Patient was hospitalized.

6957479-0 | Febrile Neutropenia
on Aug 23, 2010 Male patient from UNITED STATES , 54 years of age, weighting 207.2 lb, was diagnosed with thyroid cancer metastatic, depression (What is depression?), hypertension, diarrhoea, upper respiratory tract infection and was treated with Sorafenib (View Usage). Patient experienced the following unwanted or unexpected effects: febrile neutropenia. Sorafenib dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. During the same period patient was treated with LEVOXYL (View Levoxyl Review and Levoxyl Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), NORVASC (View Norvasc Review and Norvasc Label ), IMODIUM (1 Tablet) (View Imodium Review and Imodium Label ), ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ). Patient was hospitalized.

6957424-8 | Adrenal Insufficiency, Dyspnoea, Myocardial Infarction, Myocardial Ischaemia, Troponin T Increased
on Aug 23, 2010 Male patient from UNITED STATES , 64 years of age, weighting 134.5 lb, was diagnosed with thyroid cancer metastatic and was treated with Sorafenib (View Usage). Patient had the following side effects: adrenal insufficiency, dyspnoea, myocardial infarction, myocardial ischaemia, troponin t increased. Sorafenib dosage: Total Daily Dose: 400 Mg Unit Dose: 200 Mg. During the same period patient was treated with LEVOXYL (View Levoxyl Review and Levoxyl Label ), MOTRIN (View Motrin Review and Motrin Label ), PREVACID (View Prevacid Review and Prevacid Label ). Patient was hospitalized.

6957415-7 | Arthritis, Gout
Patient was taking Sorafenib (View Usage). After Sorafenib was administered, patient had the following side effects: arthritis (What is arthritis?), gout (What is gout?) on Aug 24, 2010 from GERMANY Additional patient health information: Male patient , 58 years of age, was diagnosed with renal cell carcinoma and. Sorafenib dosage: . During the same period patient was treated with ALLOPURINOL (Total Daily Dose: 300 Mg) (View Allopurinol Review and Allopurinol Label ), PANTOPRAZOLE (Total Daily Dose: 40 Mg) (View Pantoprazole Review and Pantoprazole Label ), SELOKEN PLUS (View Seloken Plus Review and Seloken Plus Label ), ASPIRIN (Total Daily Dose: 100 Mg) (View Aspirin Review and Aspirin Label ), AMLODIPINE (Total Daily Dose: 10 Mg) (View Amlodipine Review and Amlodipine Label ), THYREX (Total Daily Dose: 200 Mg) (View Thyrex Review and Thyrex Label ), RASILEZ (Total Daily Dose: 300 Mg) (View Rasilez Review and Rasilez Label ). Patient was hospitalized.

6957348-6 | Cerebral Infarction
Adverse event was reported on Jul 30, 2010 by a Female patient taking Sorafenib (View Usage) (Dosage: ) was diagnosed with renal cell carcinoma, hypertension, dysuria, pain (What is pain?) and. Location: UNITED STATES , 71 years of age, weighting 154.3 lb, Patient experienced the following unwanted or unexpected effects: cerebral infarction. During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), FINASTERIDE (View Finasteride Review and Finasteride Label ), ACECLOFENAC (View Aceclofenac Review and Aceclofenac Label ), CHLORPHENESIN CARBAMATE BULK EXPORT (View Chlorphenesin Carbamate Bulk-export Review and Chlorphenesin Carbamate Bulk-export Label ), REBAMIPIDE (View Rebamipide Review and Rebamipide Label ), TRAMIPHEN (View Tramiphen Review and Tramiphen Label ). Patient was hospitalized.

6957343-7 | Skin Ulcer
on Jul 11, 2010 Male patient from TAIWAN, PROVINCE OF CHINA , 56 years of age, weighting 218.3 lb, was diagnosed with hepatic neoplasm malignant and was treated with Sorafenib (View Usage). Patient had the following side effects: skin ulcer. Sorafenib dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. Patient was hospitalized.

6945569-8 | Anaemia, Dehydration, Gastrointestinal Haemorrhage, Tumour Invasion
on Aug 17, 2010 Female patient from UNITED STATES , 62 years of age, weighting 136.7 lb, was diagnosed with metastatic renal cell carcinoma, pain (What is pain?), preoperative care, decreased appetite, nausea (What is nausea?), constipation (What is constipation?) and was treated with Sorafenib (View Usage). After Sorafenib was administered, patient had the following side effects: anaemia, dehydration, gastrointestinal haemorrhage, tumour invasion. Sorafenib dosage: Total Daily Dose: 800 Mg. During the same period patient was treated with TRAMADOL HCL (Total Daily Dose: 200 Mg) (View Tramadol Hcl Review and Tramadol Hcl Label ), PENICILLIN V (Total Daily Dose: 1000 Mg) (View Penicillin V Review and Penicillin V Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), SENNA (As Used: 10-20 Mg) (View Senna Review and Senna Label ). Patient was hospitalized.

6945568-6 | Atrial Fibrillation, Blood Alkaline Phosphatase Increased, Electrolyte Imbalance, Nausea, Pain, Renal Cell Carcinoma
Patient was taking Sorafenib (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), blood alkaline phosphatase increased, electrolyte imbalance, nausea (What is nausea?), pain (What is pain?), renal cell carcinoma on Aug 20, 2010 from UNITED STATES Additional patient health information: Female patient , 62 years of age, was diagnosed with renal cell carcinoma, depression (What is depression?), prophylaxis, pain (What is pain?), nausea (What is nausea?), vitamin supplementation and. Sorafenib dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. During the same period patient was treated with CIPRALEX (View Cipralex Review and Cipralex Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), APROVEL (View Aprovel Review and Aprovel Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), PINEX (View Pinex Review and Pinex Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), EMPERAL (View Emperal Review and Emperal Label ), UNIKALK (View Unikalk Review and Unikalk Label ). Patient was hospitalized.

6944909-3 | Abdominal Pain, Diabetes Mellitus, Dyspepsia, Fatigue, Liver Function Test Abnormal
Adverse event was reported on Aug 16, 2010 by a Male patient taking Sorafenib (View Usage) (Dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg) was diagnosed with hepatic neoplasm malignant, diabetes mellitus, gout (What is gout?), hypertension, gastrooesophageal reflux disease and. Location: AUSTRALIA , 72 years of age, weighting 180.8 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), diabetes mellitus, dyspepsia, fatigue, liver function test abnormal. During the same period patient was treated with DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PROGOUT (Total Daily Dose: 300 Mg) (View Progout Review and Progout Label ), BETALOC (Total Daily Dose: 100 Mg) (View Betaloc Review and Betaloc Label ), ZESTRIL (View Zestril Review and Zestril Label ), LOVAZA (View Lovaza Review and Lovaza Label ), INSULIN NOVORAPID (View Insulin Novorapid Review and Insulin Novorapid Label ), SOMAC (View Somac Review and Somac Label ). Patient was hospitalized.

6944908-1 | Bronchitis, Encephalopathy
on Aug 17, 2010 Male patient from UNITED STATES , 72 years of age, weighting 167.6 lb, was diagnosed with hepatic neoplasm malignant, psoriasis, pain (What is pain?), type 2 diabetes mellitus and was treated with Sorafenib (View Usage). After Sorafenib was administered, patient had the following side effects: bronchitis (What is bronchitis?), encephalopathy. Sorafenib dosage: Total Daily Dose: 800 Mg. During the same period patient was treated with ATARAX (View Atarax Review and Atarax Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), NOVOMIX (View Novomix Review and Novomix Label ), ENEBREL (View Enebrel Review and Enebrel Label ). Patient was hospitalized.

6944877-4 | Hepatic Failure
on Aug 17, 2010 Female patient from UNITED STATES , 59 years of age, weighting 114.6 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic failure. Sorafenib dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. Patient was hospitalized.

6944873-7 | Haemorrhage Intracranial, Loss Of Consciousness
Patient was taking Sorafenib (View Usage). Patient had the following side effects: haemorrhage intracranial, loss of consciousness on Aug 19, 2010 from IRELAND Additional patient health information: Female patient , 74 years of age, weighting 154.3 lb, was diagnosed with gastric cancer recurrent, hypertension and. Sorafenib dosage: As Used: 400 Mg. During the same period patient was treated with ATECOR (View Atecor Review and Atecor Label ), MEGACE (View Megace Review and Megace Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), MOTILIUM (View Motilium Review and Motilium Label ), PANADOL (View Panadol Review and Panadol Label ), ANTICOAGULANTS NOS (75 Mgs) (View Anticoagulants Nos Review and Anticoagulants Nos Label ). Patient was hospitalized.